Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Dosing in Elderly Patients Undergoing Hip Replacement Surgery
NCT05567523Phase 4Completed
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Jun 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in hip fracture, sponsored by Zhenjiang First People's Hospital. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT05567523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05567523.